Postscript today launched email on a new AI-native platform, extending the company beyond SMS for the first time. Applying years of conversational AI data from millions of one-to-one shopper ...
Encellin Partners with Breakthrough T1D to Advance Immune-Protected Cell Therapy for Type 1 Diabetes
SAN FRANCISCO, NEW YORK & MONTREAL, Sept. 22, 2026—Encellin, Inc., a clinical-stage biotechnology company developing Encapsulated Cell Replacement Therapy (ENCRT), today announced a partnership with ...
A San Francisco federal court recently ruled that the Department of War (DOW) and its secretary, Pete Hegseth, “violate[d] the First Amendment” by unlawfully retaliating “against Anthropic for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results